Chengdu Guibao Science & TechnologyLtd Past Earnings Performance
Past criteria checks 2/6
Chengdu Guibao Science & TechnologyLtd has been growing earnings at an average annual rate of 14.5%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 18.2% per year. Chengdu Guibao Science & TechnologyLtd's return on equity is 9.7%, and it has net margins of 8.8%.
Key information
14.5%
Earnings growth rate
10.7%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 18.2% |
| Return on equity | 9.7% |
| Net Margin | 8.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Chengdu Guibao Science & TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,826 | 250 | 250 | 102 |
| 30 Jun 24 | 2,570 | 285 | 231 | 100 |
| 31 Mar 24 | 2,549 | 300 | 210 | 103 |
| 31 Dec 23 | 2,606 | 315 | 209 | 102 |
| 30 Sep 23 | 2,588 | 308 | 186 | 114 |
| 30 Jun 23 | 2,507 | 280 | 166 | 121 |
| 31 Mar 23 | 2,556 | 263 | 150 | 111 |
| 31 Dec 22 | 2,694 | 250 | 147 | 110 |
| 30 Sep 22 | 2,893 | 272 | 170 | 102 |
| 30 Jun 22 | 2,929 | 277 | 157 | 98 |
| 31 Mar 22 | 2,867 | 282 | 170 | 111 |
| 01 Jan 22 | 2,556 | 268 | 159 | 110 |
| 30 Sep 21 | 2,263 | 228 | 166 | 109 |
| 30 Jun 21 | 1,988 | 223 | 185 | 102 |
| 31 Mar 21 | 1,726 | 219 | 188 | 87 |
| 31 Dec 20 | 1,524 | 201 | 177 | 76 |
| 30 Sep 20 | 1,288 | 183 | 163 | 61 |
| 30 Jun 20 | 1,145 | 159 | 143 | 48 |
| 31 Mar 20 | 993 | 128 | 124 | 42 |
| 31 Dec 19 | 1,018 | 132 | 132 | 41 |
| 30 Sep 19 | 961 | 128 | 116 | 43 |
| 30 Jun 19 | 914 | 99 | 111 | 43 |
| 31 Mar 19 | 905 | 81 | 108 | 39 |
| 31 Dec 18 | 871 | 65 | 102 | 38 |
| 30 Sep 18 | 817 | 39 | 99 | 34 |
| 30 Jun 18 | 784 | 44 | 79 | 47 |
| 31 Mar 18 | 758 | 47 | 86 | 40 |
| 31 Dec 17 | 728 | 52 | 90 | 34 |
| 30 Sep 17 | 721 | 57 | 101 | 23 |
| 30 Jun 17 | 708 | 72 | 125 | 0 |
| 31 Mar 17 | 662 | 80 | 120 | 0 |
| 31 Dec 16 | 652 | 91 | 120 | 0 |
| 30 Sep 16 | 621 | 95 | 119 | 0 |
| 30 Jun 16 | 613 | 93 | 112 | 0 |
| 31 Mar 16 | 611 | 92 | 109 | 0 |
| 31 Dec 15 | 606 | 89 | 103 | 0 |
| 30 Sep 15 | 591 | 83 | 102 | 0 |
| 30 Jun 15 | 585 | 83 | 103 | 0 |
| 31 Mar 15 | 572 | 82 | 98 | 0 |
| 31 Dec 14 | 549 | 80 | 96 | 0 |
| 30 Sep 14 | 517 | 73 | 88 | 0 |
| 30 Jun 14 | 499 | 71 | 84 | 0 |
| 31 Mar 14 | 475 | 71 | 81 | 0 |
| 31 Dec 13 | 465 | 70 | 79 | 0 |
Quality Earnings: 300019 has high quality earnings.
Growing Profit Margin: 300019's current net profit margins (8.8%) are lower than last year (11.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300019's earnings have grown by 14.5% per year over the past 5 years.
Accelerating Growth: 300019's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300019 had negative earnings growth (-18.8%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).
Return on Equity
High ROE: 300019's Return on Equity (9.7%) is considered low.